Paul Tudor Kelly
Research Subjects
Research Interests
Paul Tudor Kelly has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Georgia Burton
Respiratory Department Te Whatu Ora Health New Zealand Waitaha Canterbury Christchurch New Zealand
2 shared publications - Lutz Beckert
Te Whatu Ora Waitaha Canterbury Christchurch New Zealand
2 shared publications Brooke Carroll
Te Whatu Ora Waitaha Canterbury Christchurch New Zealand
1 shared publicationChris Frampton
Department of Medicine University of Otago Christchurch New Zealand
1 shared publication- Dimitrios Alexopoulos
Division of Cardiology, Attikon University Hospital, 10431 Athens, Greece
1 shared publication - George Kassimis
Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, 54642 Thessaloniki, Greece
1 shared publication
Latest Publications
- 15 February 2026
- Published by Wiley in Respirology
- Vol. 31 (3) , 321-322
Reply to ‘The Oxygenation Benefits Provided by High‐Flow Nasal Oxygen in Bronchoscopy May be Underestimated’
- 15 February 2026
- Published by Wiley in Respirology
- Vol. 31 (3) , 321-322
Reply to ‘The Oxygenation Benefits Provided by High‐Flow Nasal Oxygen in Bronchoscopy May be Underestimated’
- Open Access
- 21 May 2025
- Published by Wiley in Respirology
- Vol. 30 (10) , 970-978
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial
Background and Objective: Oxygen desaturations and hypoxaemia are common during bronchoscopy despite the use of conventional low flow oxygen (LFO). Some researchers suggest high flow nasal oxygen (HFNO) may improve oxygenation in patients undergoing bronchoscopy; however, trials have varied widely in their methodology and patient population. Evidence of use in a broad patient cohort and assessment of other important considerations, including clinician/patient satisfaction, is lacking.We hypothesised that HFNO during bronchoscopy and EBUS would reduce desaturations/hypoxaemia, oxygen titrations, respiratory rate, and cough frequency when compared to LFO. We also explored clinician and patient satisfaction.Methods: Participants undergoing diagnostic bronchoscopy or EBUS with conscious sedation were randomised to receive LFO or HFNO. Data was collected via physiological monitoring devices, health records, and clinician/patient questions. The primary outcome was time spent with SpO2 < 90%.Results: A total of 121 participants were included. There was no difference in oxygenation and desaturations between LFO (n = 61) and HFNO (n = 60) in all procedures. This was also observed within the separate strata of bronchoscopy (n = 75) and EBUS (n = 46). HFNO reduced the respiratory rate in EBUS procedures (p < 0.05). The clinician satisfaction score was higher with HFNO in bronchoscopy procedures (p < 0.05). The requirement for oxygen titrations was lower with HFNO, but this did not reach statistical significance. There was no difference in cough frequency.Conclusion: LFO and HFNO were equally effective in maintaining oxygenation during bronchoscopy and EBUS in our population. HFNO had higher clinician satisfaction during bronchoscopy and may have a physiological advantage during EBUS as demonstrated by a lower respiratory rate. Trial Registration: ANZCTRN12623001262695 image
- 21 May 2025
- Published by Wiley in Respirology
- Vol. 30 (10) , 970-978
Open AccessHigh Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial
Background and Objective: Oxygen desaturations and hypoxaemia are common during bronchoscopy despite the use of conventional low flow oxygen (LFO). Some researchers suggest high flow nasal oxygen (HFNO) may improve oxygenation in patients undergoing bronchoscopy; however, trials have varied widely in their methodology and patient population. Evidence of use in a broad patient cohort and assessment of other important considerations, including clinician/patient satisfaction, is lacking.We hypothesised that HFNO during bronchoscopy and EBUS would reduce desaturations/hypoxaemia, oxygen titrations, respiratory rate, and cough frequency when compared to LFO. We also explored clinician and patient satisfaction.Methods: Participants undergoing diagnostic bronchoscopy or EBUS with conscious sedation were randomised to receive LFO or HFNO. Data was collected via physiological monitoring devices, health records, and clinician/patient questions. The primary outcome was time spent with SpO2 < 90%.Results: A total of 121 participants were included. There was no difference in oxygenation and desaturations between LFO (n = 61) and HFNO (n = 60) in all procedures. This was also observed within the separate strata of bronchoscopy (n = 75) and EBUS (n = 46). HFNO reduced the respiratory rate in EBUS procedures (p < 0.05). The clinician satisfaction score was higher with HFNO in bronchoscopy procedures (p < 0.05). The requirement for oxygen titrations was lower with HFNO, but this did not reach statistical significance. There was no difference in cough frequency.Conclusion: LFO and HFNO were equally effective in maintaining oxygenation during bronchoscopy and EBUS in our population. HFNO had higher clinician satisfaction during bronchoscopy and may have a physiological advantage during EBUS as demonstrated by a lower respiratory rate. Trial Registration: ANZCTRN12623001262695 image
- Open Access
- 15 March 2022
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 66, 11-18
Clinical effectiveness of thrombus aspiration during percutaneous coronary intervention for stent thrombosis in a contemporary setting
- 15 March 2022
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 66, 11-18
Open AccessClinical effectiveness of thrombus aspiration during percutaneous coronary intervention for stent thrombosis in a contemporary setting